Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants - 30/07/12

Abstract |
Background |
Respiratory syncytial virus and other respiratory tract viruses lead to common colds in most infants, whereas a minority develop acute severe bronchiolitis often requiring hospitalization. We hypothesized that such an excessive response to respiratory tract viral infection is caused by host factors reflected in pre-existing increased bronchial responsiveness.
Objective |
We sought to compare bronchial responsiveness and lung function in 1-month-old neonates who later develop acute severe bronchiolitis with those who do not.
Methods |
We measured infant lung function (n = 402) and bronchial responsiveness to methacholine (n = 363) using the raised-volume rapid thoracoabdominal compression technique before any respiratory symptoms in 1-month-old neonates from the Copenhagen Prospective Study of Asthma in Childhood birth cohort born to mothers with asthma. The children were prospectively monitored for respiratory symptoms and given a diagnosis of acute severe bronchiolitis according to a fixed algorithm.
Results |
Thirty-four (8.5%) infants had acute severe bronchiolitis before 2 years of age, 21 (62%) were hospitalized, and 23 (67%) of the cases were associated with respiratory syncytial virus. Children who later had acute severe bronchiolitis irrespective of viral species had a 2.5-fold increased responsiveness to methacholine (provocative dose of methacholine producing a 15% decrease in transcutaneous oxygen pressure [PD15]) at age 1 month compared with control subjects (median PD15 in cases vs control subjects, 0.13 vs 0.33 μmol; P = .01), whereas differences in baseline airflow were not significant for forced expiratory volume at 0.5 seconds (mean z score for cases vs control subjects, −0.18 vs −0.01; P = .36) and forced expiratory flow at 50% of forced vital capacity (mean z score for cases vs control subjects, −0.37 vs −0.09; P = .13).
Conclusion |
Bronchial hyperresponsiveness in at-risk neonates precedes acute severe bronchiolitis in response to infections with respiratory tract virus.
Le texte complet de cet article est disponible en PDF.Key words : Bronchial responsiveness, infants, lung function measurements, viral bronchiolitis
Abbreviations used : COPSAC, FEF50, FEV0.5, FVC, IQR, PD15, PtcO2, RSV
Plan
| The Copenhagen Studies on Asthma in Childhood (COPSAC) is funded by private and public research funds listed on www.copsac.com. The Lundbeck Foundation, the Danish Strategic Research Council, the Pharmacy Foundation of 1991, the Augustinus Foundation, the Danish Medical Research Council, and the Danish Pediatric Asthma Centre provided the core support for the COPSAC research center. S.L.J. is supported by a Chair from Asthma UK (CH11SJ), MRC Centre Grant G1000758, ERC FP7 Advanced grant 233015, and Predicta FP7 Collaborative Project grant 260895. |
|
| Disclosure of potential conflict of interest: S. L. Johnston has consultant arrangements with AstraZeneca, Centocor, Sanofi-Pasteur, Synairgen, GlaxoSmithKline, and Chiesi and has a share option with Synairgen. H. Bisgaard has consulted for Merck and Chiesi; has received lecture fees from Merck; receives research support from the Lundbeck Foundation, the Pharmacy Foundation of 1991, the Augustinus Foundation, the Danish Medical Research Council, and the Danish Pediatric Asthma Centre; and has provided legal consultation or expert witness testimony for the European Medicines Agency (EMEA) on guidelines on pediatric studies for documenting asthma drugs. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 130 - N° 2
P. 354 - août 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
